# China NMPA Inspection - Tonghua Changyuan Pharmaceutical Technology Co., Ltd. - September 29, 2019

Source: https://www.globalkeysolutions.net/records/china_inspection/tonghua-changyuan-pharmaceutical-technology-co-ltd/20a23d63-14b4-4b4c-8fba-03ba04f1f9d4/
Source feed: China

> China NMPA unannounced inspection for Tonghua Changyuan Pharmaceutical Technology Co., Ltd. published September 29, 2019. The Jilin Provincial Drug Administration published an announcement on September 29, 2019, detailing the proposed and actual issuance of cosmetics prod

---

## Details

- Record Type: CHINA_INSPECTION
- Title: Jilin Provincial Drug Administration's Proposed Issuance of Cosmetic Production Licenses (No. 3 of 2019)
- Company Name: Tonghua Changyuan Pharmaceutical Technology Co., Ltd.
- Publication Date: 2019-09-29
- Product Type: cosmetics
- Summary: The Jilin Provincial Drug Administration published an announcement on September 29, 2019, detailing the proposed and actual issuance of cosmetics production licenses. This notice, titled 'Proposed Issuance of a Cosmetics Production License (No. 3 of 2019),' outlines actions taken in accordance with the former State Food and Drug Administration's directives for enhancing cosmetics production licensing. The administration proposes to issue a Cosmetics Production License to Tonghua Changyuan Pharmaceutical Technology Co., Ltd., following an on-site review. This proposal is subject to public comment and supervision for five working days. Additionally, the document confirms the issuance of a Cosmetics Production License to Jilin Lanpu Haoye Technology Co., Ltd., providing details such as its registered address, production scope (General Liquid Unit - Skin Care Water), and key personnel. This announcement functions as a public disclosure for licensing activities within the National Medical Products Administration (NMPA) framework in Jilin Province, specifically concerning the administrative process of granting production licenses in the cosmetics sector. It is important to note that this document focuses on license approval and issuance, rather than detailing an unannounced inspection or identifying any violations, issues, or corrective actions typically associated with such inspections.

Company: https://www.globalkeysolutions.net/companies/tonghua-changyuan-pharmaceutical-technology-co-ltd/59073268-9572-430a-ab11-da3e868f901f/